| 摘要 |
A composition is disclosed suitable for the prevention and/or treatment of cardiovascular and neurocerebral disorders, tissue anoxic forms, muscular energy deficits, inflammatory-type abnormalitites, alterations of blood coagulation such as thrombosis, and tissue proliferation forms, that may tak e the form of a dietary supplement, dietetic support or of an actual medicine, which comprises as characterizing active ingredients: (a) propionyl L- carnitine or a pharmacologically acceptable salt thereof; and (b) an inosito l phosphate, particularly the inositol hexaphosphate (IP6).
|
